International Journal of Clinical Medicine
Vol.5 No.14(2014), Paper ID 48024, 7
pages
DOI:10.4236/ijcm.2014.514113
Safety and Efficacy of Racotumomab-Alum Vaccine as Second-Line Therapy for Advanced Non-Small Cell Lung Cancer
Eduardo Santiesteban, Leslie Perez, Sailyn Alfonso, Elia Neninger, Soraida Acosta, Yoana Flores, Maurenis Hernandez, Carmen Viada, Robin García, Meylán Cepeda, Daymys Estevez, Yoisbel Moreno, Amparo Macías
José Ramón López Tabranes Hospital, Matanzas, Cuba
Center of Molecular Immunology, Havana, Cuba
Celestino Hernández Robau Hospital, Villa Clara, Cuba
Hermanos Ameijeiras Hospital, Havana, Cuba
Saturnino Lora Hospital, Santiago de Cuba, Cuba
National Institute of Oncology and Radiobiology, Havana, Cuba
Center of Molecular Immunology, Havana, Cuba
Center of Molecular Immunology, Havana, Cuba
Hermanos Ameijeiras Hospital, Havana, Cuba
Celestino Hernández Robau Hospital, Villa Clara, Cuba
Center of Molecular Immunology, Havana, Cuba
Center of Molecular Immunology, Havana, Cuba
Center of Molecular Immunology, Havana, Cuba
Copyright © 2014 Eduardo Santiesteban, Leslie Perez, Sailyn Alfonso, Elia Neninger, Soraida Acosta, Yoana Flores, Maurenis Hernandez, Carmen Viada, Robin García, Meylán Cepeda, Daymys Estevez, Yoisbel Moreno, Amparo Macías et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Santiesteban, E. , Perez, L. , Alfonso, S. , Neninger, E. , Acosta, S. , Flores, Y. , Hernandez, M. , Viada, C. , García, R. , Cepeda, M. , Estevez, D. , Moreno, Y. and Macías, A. (2014) Safety and Efficacy of Racotumomab-Alum Vaccine as Second-Line Therapy for Advanced Non-Small Cell Lung Cancer.
International Journal of Clinical Medicine,
5, 844-850. doi:
10.4236/ijcm.2014.514113.